Zidebactam
A novel beta-lactamase inhibitor
Zidebactam is a novel beta-lactamase inhibitor that is used in combination with other antibiotics to combat antibiotic resistance. It is particularly effective against Gram-negative bacteria that produce beta-lactamase enzymes, which are responsible for breaking down beta-lactam antibiotics and rendering them ineffective.
Mechanism of Action[edit]
Zidebactam works by inhibiting the activity of beta-lactamase enzymes. These enzymes are produced by certain bacteria as a defense mechanism against beta-lactam antibiotics, such as penicillins and cephalosporins. By binding to these enzymes, zidebactam prevents them from breaking down the antibiotic, thereby restoring the antibiotic's ability to kill the bacteria.
Clinical Use[edit]
Zidebactam is not used as a standalone treatment but is combined with other antibiotics, such as cefepime, to enhance their effectiveness against resistant bacterial strains. This combination is particularly useful in treating infections caused by Enterobacteriaceae and Pseudomonas aeruginosa, which are known for their resistance to multiple drugs.
Development and Approval[edit]
Zidebactam is currently under investigation in various clinical trials to assess its safety and efficacy. It is being developed by pharmaceutical companies focusing on addressing the growing issue of antibiotic resistance. The combination of zidebactam with cefepime is one of the promising therapies in the pipeline for treating multi-drug resistant infections.
Chemical Structure[edit]
Zidebactam has a unique chemical structure that allows it to effectively inhibit beta-lactamase enzymes. Its structure is designed to mimic the natural substrates of these enzymes, allowing it to bind tightly and prevent the breakdown of co-administered antibiotics.
Pharmacokinetics[edit]
The pharmacokinetic profile of zidebactam is characterized by its ability to achieve high concentrations in the bloodstream when administered intravenously. This ensures that it can effectively reach the site of infection and exert its inhibitory effects on beta-lactamase enzymes.
Safety and Side Effects[edit]
As with any medication, the use of zidebactam can be associated with side effects. Common side effects include gastrointestinal disturbances, such as nausea and diarrhea. However, the combination therapy is generally well-tolerated, and serious adverse effects are rare.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian